Thrixen
Singapore’s Thrixen raises $7M in funding round co-led by 22Health Ventures and John Ballantyne
Thrixen, a Singapore-based medical technology start-up, has on Monday announced the successful close of an oversubscribed funding round, raising $7 million capital to accelerate the development of its innovative diagnostic technology platform for multiplex point of care testing.
April 30, 2024
Singapore’s Temasek restructures to focus on key investments
August 29, 2025
Singapore’s Temasek restructures to focus on key investments
August 29, 2025